Skip to content
RF/6A
Tissue
Choroid, retina
Disease
Normal retinal choroidal endothelium (fetal; non-tumorigenic)
Metastatic site
Not applicable (normal fetal retinal choroidal endothelial cell line)

Documents

RF/6A

Cell line · Product number 305150

RF/6A is a rhesus macaque (Macaca mulatta) retinal choroidal endothelial cell line established from fetal choroid and retina tissue. The line is grows as ...

€550.00excl. tax and shipping

Customization / Recommendations

In stock
Lot
Recommended (freshest lot)
  • CoA
  • CoA
1

01General information

Description

RF/6A is a rhesus macaque (Macaca mulatta) retinal choroidal endothelial cell line established from fetal choroid and retina tissue. The line is grows as an adherent monolayer with epithelial-like morphology. RF/6A cells retain key endothelial characteristics including expression of Factor VIII (von Willebrand factor), fibronectin, and Weibel-Palade granules detectable by electron microscopy — the latter confirming their endothelial identity. The line was originally established for studies of retinal and choroidal vascularization and has been widely adopted as a primate endothelial model for ocular angiogenesis research.

RF/6A is applicable in ocular angiogenesis research, studies of retinal and choroidal vascularization, evaluation of anti-angiogenic agents (VEGF inhibitors, bevacizumab, ranibizumab), age-related macular degeneration (AMD) modeling, diabetic retinopathy biology, and assessment of vascular permeability in the ocular microenvironment. The non-human primate (NHP) origin makes RF/6A closer to human retinal vascular biology than rodent endothelial models, particularly for studies involving primate-specific VEGF isoform responses and ocular pharmacology. The line is commonly used in tube formation assays, migration assays, and VEGF-stimulation experiments.

Tissue
Choroid, retina
Disease
Normal retinal choroidal endothelium (fetal; non-tumorigenic)
Metastatic site
Not applicable (normal fetal retinal choroidal endothelial cell line)
Applications
Ocular angiogenesis research; retinal and choroidal vascularization; anti-VEGF therapy evaluation (bevacizumab, ranibizumab); AMD and diabetic retinopathy modeling; tube formation assays; vascular permeability; NHP primate retinal endothelial model

02Classification

Organism
Rhesus macaque
Sex
Unspecified
Growth properties
Adherent
GMO status
Non-GMO
GMO status details
No genetic modification; wildtype rhesus macaque fetal retinal choroidal endothelial cell line
Biosafety level
1

03Characteristics

Morphology
Epithelial-like
Cell type
Endothelial cells
Doubling time
approx. 24 to 36 hours

04Identifiers

Citation
RF/6A (Cytion catalog number 305150)
NCBI TaxID
9544
Cellosaurus
CVCL_4552

05Expression and susceptibility

Protein expression
Factor Ⅷ, Fibronectin

06Handling and culture

Culture medium
EMEM (MEM Eagle), w: 2 mM L-Glutamine, w: 2.2 g/L NaHCO3, w: EBSS (Cytion article number 820100a)
Incubation atmosphere

37°C, 5% CO2, humidified atmosphere.

Supplements
Supplement the medium with 10% FBS and 1% NEAA
Dissociation reagent
Accutase
Subculturing
Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium.
Split ratio
1 to 5
Seeding density
1 to 2 × 10⁴ cells/cm²
Fluid renewal
2 to 3 times per week
Post-thaw recovery
After thawing, plate the cells at 5 × 10⁴ cells/cm² and allow at least 24 hours for adherence before the first medium change. Do not allow cultures to reach full confluency as contact inhibition may reduce endothelial phenotype.
Thawing and culturing
  1. Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.

  2. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.

  3. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.

  4. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.

  5. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.

  6. Centrifuge the mixture at 300 x g for 3 minutes to separate the cells and carefully discard the supernatant containing residual freezing medium.

  7. Gently resuspend the cell pellet in 10 ml of fresh culture medium. For adherent cells, divide the suspension between two T25 culture flasks; for suspension cultures, transfer all the medium into one T25 flask to promote effective cell interaction and growth.

  8. Adhere to established subculture protocols for continued growth and maintenance of the cell line, ensuring reliable experimental outcomes.

07Quality control and cryopreservation

Sterility

Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods.

To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections.

Freeze medium
As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress.
Storage conditions

For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Shipping conditions

Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.

08Donor

Donor age
Fetus
Ethnicity
Not applicable (non-human primate cell line; Macaca mulatta)